This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Apperley J, Carreras E, Gluckman E, Masszi T (eds). Early complications after HSCT. The EBMT Handbook on Haematopoietic Stem Cell Transplantation, 6th edn. Forum service editore: Genoa, Italy, 2012, pp 176–179.
Khojasteh NH, Zakerinia M, Ramzi M, Haghshenas M . A new regimen of MESNA (2-mercaptoethanesulfonate) effectively prevents cyclophosphamide-induced hemorrhagic cystitis in bone marrow transplant recipients. Transplant Proc 2000; 32: 596.
Brock N, Pohl J . The development of MESNA for regional detoxification. Cancer Treat Rev 1983; 10 (Suppl A): 33–43.
Haselberger MB, Schwinghammer TL . Efficacy of MESNA for prevention of hemorrhagic cystitis after high-dose cyclophosphamide therapy. Ann Pharmacother 1995; 29: 918–921.
Korkmaz A, Topal T, Oter S . Pathophysiological aspects of cyclophosphamide and ifosfamide induced hemorrhagic cystitis; implication of reactive oxygen and nitrogen species as well as PARP actication. Cell Biol Toxicol 2007; 23: 303–312.
Haines HL, Laskin BL, Goebel J, Davies SM, Yin HJ, Lawrence J et al. Blood, and not urine, BK viral load predicts renal outcome in children with hemorrhagic cystitis following hematopoietic stem cell transplantation. Biol Blood Marrow Transplant 2011; 17: 1512–1519.
Lima MV, Ferreira FV, Macedo FY, de Castro Brito GA, Ribeiro RA . Histological changes in bladders of patients submitted to ifosfamide chemotherapy even with MESNA prophylaxis. Cancer Chemother Pharmacol 2007; 59: 643–650.
Han W, Lu DP, Huang XJ, Liu KY, Chen H, Xu LP et al. Mismatched hematopoietic stem cell transplantation using GIAC protocol: report of 100 cases. Zhonghua Xue Ye Xue Za Zhi 2004; 25: 453–457.
Silva Lde P, Patah PA, Saliba RM, Szewczyk NA, Gilman L, Neumann J et al. Hemorrhagic cystitis after allogeneic hematopoietic stem cell transplants is the complex result of BK virus infection, preparative regimen intensity and donor type. Haematologica 2010; 95: 1183–1190.
Giraud G, Bogdanovic G, Priftakis P, Remberger M, Svahn BM, Barkholt L et al. The incidence of hemorrhagic cystitis and BK-viruria in allogeneic hematopoietic stem cell recipients according to intensity of the conditioning regimen. Haematologica 2006; 91: 401–404.
Takamoto S, Sakura N, Yashiki M, Kojima T . Inactivation of acrolein by sodium 2-mercaptoethanesulfonate using headspace-solid-phase microextraction gas chromatography and mass spectrometry. J Chromatogr B Analyt Technol Biomed Life Sci 2003; 791: 365–369.
Takamoto S, Sakura N, Namera A, Yashiki M . Monitoring of urinary acrolein concentration in patients receiving cyclophosphamide and ifosphamide. J Chromatogr B Analyt Technol Biomed Life Sci 2004; 806: 59–63.
Markman M, Kennedy A, Webster K, Kulp B, Peterson G, Belinson J . Continuous subcutaneous administration of MESNA to prevent ifosfamide-induced hemorrhagic cystitis. Semin Oncol 1996; 23 (Suppl 6): 97–98.
Dalianis T, Ljungman P . Full myeloablative conditioning and an unrelated HLA mismatched donor increase the risk for BK virus-positive hemorrhagic cystitis in allogeneic hematopoetic stem cell transplanted patients. Anticancer Res 2011; 31: 939–944.
Acknowledgements
We thank the NSFC (30901367 and 31070866), Outstanding Young Teachers’ foundation of SMU (C1031694) and the Natural Science Foundation of Nanfang Hospital (No. 2010037, G2011021). We thank Professor Ning Gan for detecting MESNA.
Author information
Authors and Affiliations
Corresponding authors
Ethics declarations
Competing interests
The authors declare no conflict of interest.
Rights and permissions
About this article
Cite this article
Jiang, Q., Huang, H., Liu, Q. et al. Continuous IV infusion of MESNA can prevent hemorrhagic cystitis in HSCT and retain MESNA concentration in urine. Bone Marrow Transplant 50, 1490–1492 (2015). https://doi.org/10.1038/bmt.2015.197
Published:
Issue Date:
DOI: https://doi.org/10.1038/bmt.2015.197
This article is cited by
-
Use of high-dose mesna and hyperhydration leads to lower incidence of hemorrhagic cystitis after posttransplant cyclophosphamide-based allogeneic transplantation
Bone Marrow Transplantation (2021)
-
Impact of extended infusional mesna prophylaxis on the incidence of BK viruria and hemorrhagic cystitis following post-transplantation cyclophosphamide and CTLA4Ig-based haploidentical transplantation
Annals of Hematology (2020)